Search company, investor...
Search

The profile is currenly unclaimed by the seller. All information is provided by CB Insights.

encoregroup.aero

Stage

Acquired | Acquired

About EnCore

EnCore is comprised of four aerospace companies: Interiors, Composite Structures, Lift by EnCore, and EnCore International.

EnCore Headquarters Location

5511 Skylab Rd

Huntington Beach, California, 92647,

United States

+1 (949) 559-0930

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

EnCore Patents

EnCore has filed 146 patents.

The 3 most popular patent topics include:

  • Orthopedic surgical procedures
  • Muscles of the upper limb
  • Shoulder
patents chart

Application Date

Grant Date

Title

Related Topics

Status

4/24/2020

8/9/2022

Shoulder, Orthopedic surgical procedures, Muscles of the upper limb, Upper limb anatomy, Prosthetics

Grant

Application Date

4/24/2020

Grant Date

8/9/2022

Title

Related Topics

Shoulder, Orthopedic surgical procedures, Muscles of the upper limb, Upper limb anatomy, Prosthetics

Status

Grant

  • Where is EnCore's headquarters?

    EnCore's headquarters is located at 5511 Skylab Rd, Huntington Beach.

  • What is EnCore's latest funding round?

    EnCore's latest funding round is Acquired.

  • Who are the investors of EnCore?

    Investors of EnCore include Boeing.

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.